BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3756141)

  • 1. Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization.
    Bock SC; Skriver K; Nielsen E; Thøgersen HC; Wiman B; Donaldson VH; Eddy RL; Marrinan J; Radziejewska E; Huber R
    Biochemistry; 1986 Jul; 25(15):4292-301. PubMed ID: 3756141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11.
    Davis AE; Whitehead AS; Harrison RA; Dauphinais A; Bruns GA; Cicardi M; Rosen FS
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3161-5. PubMed ID: 3458172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of the cDNA coding for human C1 inhibitor.
    Rauth G; Schumacher G; Buckel P; Müller-Esterl W
    Protein Seq Data Anal; 1988; 1(4):251-7. PubMed ID: 3393514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and cDNA cloning of the human C1 inhibitor. Intron-exon junctions and comparison with other serpins.
    Carter PE; Dunbar B; Fothergill JE
    Eur J Biochem; 1988 Apr; 173(1):163-9. PubMed ID: 3267220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG mutations in the reactive site of human C1 inhibitor.
    Skriver K; Radziejewska E; Silbermann JA; Donaldson VH; Bock SC
    J Biol Chem; 1989 Feb; 264(6):3066-71. PubMed ID: 2563376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant.
    Bos IG; Lubbers YT; Roem D; Abrahams JP; Hack CE; Eldering E
    J Biol Chem; 2003 Aug; 278(32):29463-70. PubMed ID: 12773530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily.
    Tosi M; Duponchel C; Bourgarel P; Colomb M; Meo T
    Gene; 1986; 42(3):265-72. PubMed ID: 3089875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional structure and molecular modelling of C1- inhibitor.
    Perkins SJ
    Behring Inst Mitt; 1993 Dec; (93):63-80. PubMed ID: 8172587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary and acquired deficiencies of C1 inhibitor.
    Davis AE
    Immunodefic Rev; 1989; 1(3):207-26. PubMed ID: 2698641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.
    Verpy E; Couture-Tosi E; Eldering E; Lopez-Trascasa M; Späth P; Meo T; Tosi M
    J Clin Invest; 1995 Jan; 95(1):350-9. PubMed ID: 7814636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss.
    Wang T; Secombes CJ
    Immunogenetics; 2003 Dec; 55(9):615-28. PubMed ID: 14628103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of active human C1 inhibitor serpin domain in Escherichia coli.
    Lamark T; Ingebrigtsen M; Bjørnstad C; Melkko T; Mollnes TE; Nielsen EW
    Protein Expr Purif; 2001 Jul; 22(2):349-58. PubMed ID: 11437612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
    Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
    J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular defects in hereditary angioneurotic edema.
    Bissler JJ; Aulak KS; Donaldson VH; Rosen FS; Cicardi M; Harrison RA; Davis AE
    Proc Assoc Am Physicians; 1997 Mar; 109(2):164-73. PubMed ID: 9069585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements.
    Stoppa-Lyonnet D; Carter PE; Meo T; Tosi M
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1551-5. PubMed ID: 2154751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain.
    Hillarp A; Dahlbäck B
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1183-7. PubMed ID: 2300577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene.
    Levy NJ; Ramesh N; Cicardi M; Harrison RA; Davis AE
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):265-8. PubMed ID: 2296585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sequence of a cDNA encoding functional murine C1-inhibitor protein.
    Russell JA; Whaley K; Heaphy S
    Biochim Biophys Acta; 1997 May; 1352(2):156-60. PubMed ID: 9199246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema.
    Cicardi M; Igarashi T; Kim MS; Frangi D; Agostoni A; Davis AE
    J Clin Invest; 1987 Dec; 80(6):1640-3. PubMed ID: 2890659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.